(Q40382726)

20 September 2017

title

Inhibition of the KCa3.1 Channel Alleviates Established Pulmonary Fibrosis in a Large Animal Model (English)

1 reference

20 September 2017

1 reference

Emmanuel Koumoundouros

3

Emmanuel Koumoundouros

0 references

Barbara Bacci

Barbara Bacci

2

0 references

Cameron Nowell

Cameron J Nowell

6

0 references

Glen P Westall

Glen Westall

9

0 references

Peter Bradding

Peter Bradding

7

0 references

author name string

Louise Organ

1

1 reference

20 September 2017

Emmanuel Koumoundouros

3

1 reference

20 September 2017

Wayne G Kimpton

4

1 reference

20 September 2017

Chrishan S Samuel

5

1 reference

20 September 2017

Katy M Roach

8

1 reference

20 September 2017

Jade Jaffar

10

1 reference

20 September 2017

Ken J Snibson

11

1 reference

20 September 2017

language of work or name

1 reference

6 January 2017

1 reference

American Journal of Respiratory Cell and Molecular Biology

20 September 2017

published in

1 reference

20 September 2017

volume

56

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

539-550

1 reference

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Pathogenesis of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

The versatility and universality of calcium signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

KCa3.1 Ca2+ activated K+ channels regulate human airway smooth muscle proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Complementary roles of KCa3.1 channels and β1-integrin during alveolar epithelial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Functional KCa3.1 K+ channels are required for human fibrocyte migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by KCa3.1 K(+) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Therapeutic potential of KCa3.1 blockers: recent advances and promising trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

K(Ca)3.1 channel-blockade attenuates airway pathophysiology in a sheep model of chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

A novel segmental challenge model for bleomycin-induced pulmonary fibrosis in sheep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Determination of collagen content, concentration, and sub-types in kidney tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Loss of PPARγ expression by fibroblasts enhances dermal wound closure

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Disruption of Calcium Signaling in Fibroblasts and Attenuation of Bleomycin-Induced Fibrosis by Nifedipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2016-0092OC

21 January 2018

Identifiers

DOI

10.1165/RCMB.2016-0092OC

1 reference

20 September 2017

1 reference